Review article · 2022
Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review
The Lancet Infectious Diseases, 22(8), e208–e220 · Published 3 March 2022 · DOI 10.1016/s1473-3099(21)00612-5
In brief
“Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review” is a 2022 review article by Saartje Uyttebroek and 16 co-authors, published in The Lancet Infectious Diseases. OpenAlex counts 465 citations as of 15 November 2026, which puts it in the top 8% of works published in 2022 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 465
- Most cited in
- 2026 (128)
- Field-weighted impact
- 7.96
- References
- 77
- Authors
- 17
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Uyttebroek, S., Chen, B., Onsea, J., Ruythooren, F., Debaveye, Y. A., Devolder, D., Spriet, I., Depypere, M., Wagemans, J., Lavigne, R., Pirnay, J.-P., Merabishvili, M., De Munter, P., Peetermans, W. E., Dupont, L., Van Gerven, L., & Metsemakers, W. (2022). Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review. The Lancet Infectious Diseases, 22(8), e208–e220. https://doi.org/10.1016/s1473-3099(21)00612-5
MLA 9
Uyttebroek, Saartje, et al. “Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review.” The Lancet Infectious Diseases, vol. 22, no. 8, 2022, pp. e208–e220. https://doi.org/10.1016/s1473-3099(21)00612-5.
Chicago
Uyttebroek, Saartje, Baixing Chen, Jolien Onsea, Fred Ruythooren, Yves A. Debaveye, David Devolder, Isabel Spriet, et al. 2022. “Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review.” The Lancet Infectious Diseases 22 (8): e208–e220. https://doi.org/10.1016/s1473-3099(21)00612-5.
Harvard
Uyttebroek, S. et al. (2022) ‘Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review’, The Lancet Infectious Diseases, 22(8), pp. e208–e220. doi:10.1016/s1473-3099(21)00612-5.
IEEE
S. Uyttebroek et al., “Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review,” The Lancet Infectious Diseases, vol. 22, no. 8, pp. e208–e220, 2022, doi: 10.1016/s1473-3099(21)00612-5.
BibTeX
@article{uyttebroek2022safety,
title = {{Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review}},
author = {Uyttebroek, Saartje and Chen, Baixing and Onsea, Jolien and Ruythooren, Fred and Debaveye, Yves A. and Devolder, David and Spriet, Isabel and Depypere, Melissa and Wagemans, Jeroen and Lavigne, Rob and Pirnay, Jean-Paul and Merabishvili, Maya and De Munter, Paul and Peetermans, Willy E and Dupont, Lieven and Van Gerven, Laura and Metsemakers, Willem‐Jan},
journal = {The Lancet Infectious Diseases},
year = {2022},
volume = {22},
number = {8},
pages = {e208--e220},
doi = {10.1016/s1473-3099(21)00612-5},
url = {https://doi.org/10.1016/s1473-3099(21)00612-5}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2021 | 2 | |
| 2022 | 28 | |
| 2023 | 81 | |
| 2024 | 107 | |
| 2025 | 119 | |
| 2026 | 128 |
Its field-weighted citation impact is 7.96: it has been cited 7.96 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
- phage therapy
- bacteriophages
- antibiotic-resistant bacterial infections
- difficult-to-treat infections
- phage safety
- phage efficacy
- antibiotic alternatives
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Uyttebroek, S., Chen, B., Onsea, J., Ruythooren, F., Debaveye, Y. A., Devolder, D., Spriet, I., Depypere, M., Wagemans, J., Lavigne, R., Pirnay, J.-P., Merabishvili, M., De Munter, P., Peetermans, W. E., Dupont, L., Van Gerven, L., & Metsemakers, W. (2022). Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review. The Lancet Infectious Diseases, 22(8), e208–e220. https://doi.org/10.1016/s1473-3099(21)00612-5
How many times has this paper been cited?
465 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Saartje Uyttebroek, Baixing Chen, Jolien Onsea, Fred Ruythooren, Yves A. Debaveye, David Devolder, Isabel Spriet, Melissa Depypere, Jeroen Wagemans, Rob Lavigne, Jean-Paul Pirnay, Maya Merabishvili and 5 more.
What is the DOI of this paper?
10.1016/s1473-3099(21)00612-5. The permanent link is https://doi.org/10.1016/s1473-3099(21)00612-5.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.